PARI
Stefan Obert has a wealth of experience in business development, M&A, and corporate development. Stefan is currently serving as the Head of Business Development - Senior Director at PARI. Prior to this, Stefan held the position of Head of M&A and Licensing at Woerwag Pharma GmbH & Co. KG and Manager Strategic Corporate Development. Additionally, they worked as a Project Manager and Associate at IMAP M&A Consultants AG, where they focused on growth strategies, target identification and assessment of synergies, market and competitor analysis, and business valuation. Stefan also served as a Project Manager at Clearwater International Corporate Finance.
Stefan Obert completed their education in a chronological manner. Stefan started their academic journey by attending the Stadtsparkasse Baden-Baden from 1999 to 2001, where they obtained a degree in Bankaufmann with a focus on Banking and Financial Support Services.
After that, Stefan joined the University of Cooperative Education in Mannheim from 2001 to 2004. During this time, they pursued a degree in Diplom-Betriebswirt, specializing in Business Administration.
Later, Stefan enrolled at the Henley Business School from 2010 to 2013. Stefan undertook an Executive MBA program, aiming to enhance their knowledge in Business Administration and Management, specifically in a general context.
This person is not in any offices
PARI
1 followers
PARI was founded in Wuppertal in 1906 and has progressed during its more than 100 years of company history from a small manufacturer to a globally respected specialist in respiratory therapy. At present, the PARI business group is headquartered in Starnberg, Germany with additional locations in Weilheim, Germany (PARItec, production) and Gräfelfing, Germany (PARI Pharma, medicinal products and eFlow technology). In addition, there are international branch offices and a worldwide distribution network. As a manufacturer of medical devices with a focus on respiratory therapy, PARI has been the brand to trust for doctors, pharmacists and patients, for many decades. Continuous development and steady growth enabled PARI to expand their market leadership in Germany for equipment, saline solutions and respiratory aids. PARI is the global market leader in the field of nebuliser devices for cystic fibrosis. PARI offers specially optimized devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases. A broad portfolio is used to provide patients with comprehensive care, ranging from diagnosis and treatment to monitoring. PARI’s mission is to improve the lives of those affected by respiratory diseases and those who provide care to them. In addition to innovative products and tailored solutions, PARI also offers comprehensive services for users, medical professionals and distribution partners. Are you seeking new career opportunities? Visit our website www.pari.com and find out more about open positions.